The F-4 filing and upsized financing are positive signals of deal progression and capital commitment. Monitor for SEC effectiveness, shareholder vote date, and redemption levels — high redemptions could reduce cash to balance sheet. The quantum computing peer valuation slide shows Pasqal at $2.0B pre-money vs. IonQ at $10.7B and Rigetti at $3.3B, suggesting potential upside if commercial revenue growth continues.
Price Chart
Executive Summary
Bleichroeder Acquisition Corp. II (BBCQU) filed an investor presentation and press release announcing the public filing of the F-4 registration statement for its de-SPAC merger with Pasqal, a neutral-atom quantum computing company. The filing also details a $50M increase in the committed convertible financing to $250M and a merger sub assignment to a new French entity. The transaction values Pasqal at $2.0B pre-money and is expected to provide ~$500M in gross proceeds, marking a key procedural milestone toward closing in H2 2026.
Key Financial Metrics
Key Facts
- Pasqal valued at $2.0B pre-money in the de-SPAC merger with Bleichroeder Acquisition Corp. II.
- Committed convertible financing increased by $50M to $250M (to purchase $312.5M aggregate principal amount of convertible bonds and warrants).
- F-4 registration statement filed with the SEC; deal expected to close in H2 2026.
- Pasqal reports €16.5M commercial revenue in 2025 and €66M+ in booked/awarded business (including grants) as of March 2026.
- Pasqal has 10 QPUs (7 installed, 3 in production) and has demonstrated quantum advantage in materials science.
- Post-de-SPAC cash to balance sheet estimated at $649.1M (assuming no redemptions), including $290.6M from SPAC trust and $144.6M Pasqal existing cash.
- Pro forma equity value at closing estimated at $2.64B with 264.4M shares outstanding at $10.00/share.
- Existing Pasqal shareholders to own ~76%, Bleichroeder shareholders ~11%, convertible investors ~10%, Bleichroeder sponsor ~3%.
Financial Impact
Transaction provides ~$500M gross proceeds to Pasqal; $250M committed convertible financing upsized by $50M; Pasqal 2025 commercial revenue €16.5M; €66M+ booked/awarded business.
Risk Factors
- De-SPAC completion risk: subject to SEC effectiveness, shareholder approval, regulatory approvals, and Nasdaq listing.
- Redemption risk: significant SPAC redemptions would reduce cash proceeds below the $649.1M estimate.
- Execution risk: Pasqal's roadmap to 10,000+ physical qubits and 200+ logical qubits by 2029 is ambitious and unproven at scale.
- Competitive risk: quantum computing market is early-stage with multiple modalities (superconducting, trapped ion, photonic) competing for dominance.
- Dilution: pro forma shares outstanding of 264.4M at $10/share implies significant dilution for SPAC holders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001213900-26-061047 |
| Document: ea0292111-8k425_bleichro2.htm | 0001213900-26-061047 |
| Document: ea029211101ex99-2.htm | 0001213900-26-061047 |
| Document: ea029211101ex2-1.htm | 0001213900-26-061047 |
| Document: ea029211101ex10-1.htm | 0001213900-26-061047 |
| Document: ea029211101ex10-2.htm | 0001213900-26-061047 |
| Document: 0001213900-26-061047-index-headers.html | 0001213900-26-061047 |
| Document: 0001213900-26-061047-index.html | 0001213900-26-061047 |
| Document: 0001213900-26-061047.txt | 0001213900-26-061047 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 26, 2026 21w ago | 425 | $12.47 $11.11 | ▼ −10.91% | ▼ −12.79% | — |
May 26, 2026 21w ago | 8-K | $12.47 $11.11 | ▼ −10.91% | ▼ −12.79% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers